Leukemia mortality (left) and overall survival (right) in mice that received transplants of BCR-ABL-transduced syngeneic bone marrow and T-cell-depleted allogeneic bone marrow. Allogeneic donor splenocytes were injected at the time of the transplantation or as DLIs starting on day 14.